Frank M. Balis, M.D.
Pediatric Oncology Branch
Head, Pharmacology and Experimental
Therapeutics Section
Senior Investigator
National Cancer Institute
9000 Rockville Pike
Building 10, Room 13C103
Bethesda, MD 20982
Fax: 301-402-0575
bakisf@mail.nih.gov
Dr. Balis received his B.S. in zoology from the University of North Carolina in 1971 and his M.D. from Vanderbilt University in 1975. He completed a pediatric residency at Vanderbilt Children's Hospital in 1978 followed by 4 years of fellowship training in pediatric hematology/oncology at the Children's Hospital in Seattle and the Fred Hutchinson Cancer Research Center. Dr. Balis came to the Pediatric Oncology Branch in 1982 as a clinical associate and became a senior investigator in the Branch in 1988. Dr. Balis is the head of the Pharmacology and Experimental Therapeutics Section and the Clinical Director of NCI. He is board certified in pediatrics and pediatric hematology/oncology.
Dr. Balis' Clinical Trials:
NCI is currently conducting the following trials for pediatric patients with medullary thyroid cancer or solid tumors. Click on the trials below for additional details, including a summary of eligibility criteria, treatment plan, and information on how to contact the study team directly.